← All trials
NCT04456608
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2016
- Primary completion
- Jul 31, 2021
- Completion date
- Jul 31, 2022
- First posted
- Jul 2, 2020
- Last posted
- Jul 2, 2020
- Enrollment
- 150
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of WashingtonLead sponsor
- University of WashingtonOverall official - principal investigator
- University of WashingtonReponsible party - principal investigator
- Oregon Health and Science UniversityCollaborator
- National Institute of General Medical Sciences (NIGMS)Collaborator
- University of MontanaCollaborator
- Southcentral FoundationCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.